Filter posts

The Investment Landscape in Brazil

Brazil has been at the forefront of biotech news recently, with China announcing plans to …

BIO Deputy General Counsel Testifies on Patent Reform

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front …

Biotech Stocks: Perspective in a Bull Market

Investors are increasingly interested in biotechnology based on scientific breakthroughs, an improved regulatory environment, strong …

BIO Announces Cleantech Investor Speakers for 2014 World Congress

Emerging companies to showcase their ground-breaking achievements  A selective group of CEOs and COOs from …

Buy Side Investors Bullish Ahead of 2014 BIO CEO & Investor Conference

2013 was a record year for the biotech sector, with the NASDAQ Biotechnology Index hitting …

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Is 2014 a good time to invest in biotech? How many biotech IPOs will there …

What’s Behind the Biotech IPO Boom?

Everyone knows that it’s been a knock-out year for the biotech sector in the public …

Fewer Small Public Biotechs Today

A lot can happen in six years. The number of active biotech companies currently trading …

VIDEO: Public Policies to Promote the Innovation Economy

What can lawmakers do to make the US more competitive globally and encourage investment in …

Emerging Company Policy Deconstructed: Fostering Innovation Act (H.R. 2629)

In a nutshell: Representative Michael Fitzpatrick (R-PA) introduced H.R. 2629, the Fostering Innovation Act, to …